What is the Future of Genomic Assays in Cancer Care?
The future of genomic assays in cancer care is promising, with ongoing research aimed at improving the accuracy, efficiency, and accessibility of these tests. Advances in next-generation sequencing technologies are expected to further enhance the ability to detect rare and complex genetic alterations. Additionally, the development of more targeted therapies based on the findings from genomic assays will likely continue to improve patient outcomes and expand the role of personalized medicine in oncology.
